KBL Merger Corp. IV (KBLM)
| Market Cap | 27.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.84M |
| Shares Out | 4.48M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | Nov 6, 2021 |
| Last Price | $4.99 |
| Previous Close | $4.99 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 6.04 |
| Day's Range | 4.60 - 6.05 |
| Day's Volume | 160,754 |
| 52-Week Range | 4.60 - 11.50 |
News
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire ...
Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp...
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire ...
KBL Merger Corp. IV (NASDAQ: KBLM) on Friday announced its acquisition of a new cannabis biotech company CannBioRx Life Sciences Corp.
About KBLM
KBL Merger IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal ... [Read more...]
| Industry Shell Companies | IPO Date Jun 2, 2017 |
| CEO Marlene R. Krauss | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol KBLM |